best stock from 1 jan 2020 to 30 apr 2020

Fresh2 (FRES) had the highest return between January 1, 2020 and April 30, 2020 by a US stock, returning 2,664,198.4%.

ASSET DATE % RETURN
Fresh2 (FRES)
1/1/2020 - 4/30/2020
2,664,198.4%
Ainos (AIMD)
1/1/2020 - 4/30/2020
5,400%
Co-Diagnostics (CODX)
1/1/2020 - 4/30/2020
1,160%
Vaxart (VXRT)
1/1/2020 - 4/30/2020
705.97%
Genprex (GNPX)
1/1/2020 - 4/30/2020
552.94%
Capricor Therapeutics (CAPR)
1/1/2020 - 4/30/2020
438.46%
Zhongchao  (ZCMD)
1/1/2020 - 4/30/2020
416.13%
Liberty Tripadvisor (LTRPB)
1/1/2020 - 4/30/2020
410.52%
Novavax (NVAX)
1/1/2020 - 4/30/2020
354.39%
TOMI Environmental Solutions (TOMZ)
1/1/2020 - 4/30/2020
335.1%
Ibio (IBIO)
1/1/2020 - 4/30/2020
324.24%
Bit Digital (BTBT)
1/1/2020 - 4/30/2020
289.47%
HIVE Blockchain Technologies (HIVE)
1/1/2020 - 4/30/2020
282.76%
Alpha Pro Tech (APT)
1/1/2020 - 4/30/2020
273.71%
AIM ImmunoTech (AIM)
1/1/2020 - 4/30/2020
264.91%
Inovio Pharmaceuticals (INO)
1/1/2020 - 4/30/2020
254.87%
Kaival Brands Innovations (KAVL)
1/1/2020 - 4/30/2020
247.22%
Mediaco (MDIA)
1/1/2020 - 4/30/2020
240.91%
NFT (MI)
1/1/2020 - 4/30/2020
240.66%
Ageagle Aerial Systems (UAVS)
1/1/2020 - 4/30/2020
222.22%
LightPath Technologies (LPTH)
1/1/2020 - 4/30/2020
220.83%
Arcturus Therapeutics (ARCT)
1/1/2020 - 4/30/2020
217.39%
BTCS (BTCS)
1/1/2020 - 4/30/2020
211.72%
PAVmed Inc - Series Z (PAVMZ)
1/1/2020 - 4/30/2020
178.06%
Adaptimmune Therapeutics (ADAP)
1/1/2020 - 4/30/2020
175.41%